1 |
Macara, I. G., Lounsbury, K. M., Richards, S. A., McKiernan, C. and Bar-Sagi, D. (1996) The Ras superfamily of GTPases. FASEB. J. 10, 625-630.
DOI
|
2 |
Schaeffer, H. J. and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 19, 2435-2444.
|
3 |
Wellbrock, C., Karasarides, M. and Marais, R. (2004) The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875-885.
DOI
ScienceOn
|
4 |
Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
DOI
ScienceOn
|
5 |
Johnson, G. L. and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
DOI
ScienceOn
|
6 |
Murphy, L. O. and Blenis, J. (2006) MAPK signal specificity: the right place at the right time. Trends. Biochem. Sci. 31, 268-275.
DOI
ScienceOn
|
7 |
Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288 (Pt 2), 351-355.
DOI
|
8 |
Ramos, J. W. (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 40, 2707-2719.
DOI
ScienceOn
|
9 |
Yip-Schneider, M. T., Lin, A., Barnard, D., Sweeney, C. J. and Marshall, M. S. (1999) Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite active K-ras expression. Int. J. Oncol. 15, 271-279.
|
10 |
Yip-Schneider, M. T., Lin, A. and Marshall, M. S. (2001) Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem. Biophys. Res. Commun. 280, 992-997.
DOI
ScienceOn
|
11 |
Luo, W. and Sharif, M. (1999) Stable expression of activated Ki-Ras does not constitutively activate the mitogen-activated protein kinase pathway but attenuates epidermal growth factor receptor activation in human astrocytoma cells. Int. J. Oncol. 14, 53-62.
|
12 |
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J. and Mustelin, T. (2004) Protein tyrosine phosphatases in the human genome. Cell 117, 699-711.
DOI
ScienceOn
|
13 |
Kondoh, K. and Nishida, E. (2007) Regulation of MAP kinases by MAP kinase phosphatases. Biochim. Biophys. Acta. 1773, 1227-1237.
DOI
ScienceOn
|
14 |
Owens, D. M. and Keyse, S. M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213.
DOI
ScienceOn
|
15 |
Dickinson, R. J. and Keyse, S. M. (2006) Diverse physiological functions for dual-specificity MAP kinase phosphatases. J. Cell Sci. 119, 4607-4615.
DOI
ScienceOn
|
16 |
Groom, L. A., Sneddon, A. A., Alessi, D. R., Dowd, S. and Keyse, S. M. (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15, 3621-3632.
|
17 |
Muda, M., Boschert, U., Dickinson, R., Martinou, J. C., Martinou, I., Camps, M., Schlegel, W. and Arkinstall, S. (1996) MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271, 4319-4326.
DOI
|
18 |
Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A. and Arkinstall, S. (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208.
DOI
ScienceOn
|
19 |
Shin, S. Y., Bahk, Y. Y., Ko, J., Chung, I. Y., Lee, Y. S., Downward, J., Eibel, H., Sharma, P. M., Olefsky, J. M., Kim, Y. H., Lee, B. and Lee, Y. H. (2006) Suppression of Egr-1 transcription through targeting of the serum response factor by active H-Ras. EMBO. J. 25, 1093-1103.
DOI
ScienceOn
|
20 |
Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G. and Keyse, S. M. (2008) Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter. Biochem. J. 412, 287-298.
DOI
ScienceOn
|
21 |
Downward, J. (2003) Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
DOI
ScienceOn
|
22 |
Nunes-Xavier, C. E., Tarrega, C., Cejudo-Marin, R., Frijhoff, J., Sandin, A., Ostman, A. and Pulido, R. (2010) Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester. J. Biol. Chem. 285, 26417-26430.
DOI
ScienceOn
|
23 |
Furukawa, T., Tanji, E., Xu, S. and Horii, A. (2008) Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells. Biochem Biophys Res. Commun. 377, 317-320.
DOI
ScienceOn
|
24 |
Zhang, Z., Kobayashi, S., Borczuk, A. C., Leidner, R. S., Laframboise, T., Levine, A. D. and Halmos, B. (2010) Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of active ERK signaling in lung cancer cells. Carcinogenesis 31, 577-586.
DOI
ScienceOn
|
25 |
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
DOI
ScienceOn
|
26 |
Vasudevan, K. M., Burikhanov, R., Goswami, A. and Rangnekar, V. M. (2007) Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res. 67, 10343-10350.
DOI
ScienceOn
|
27 |
Zimmermann, S. and Moelling, K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
DOI
ScienceOn
|
28 |
Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D. and Glass, D. J. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
DOI
|
29 |
McCormick, F. (1999) Signalling networks that cause cancer. Trends. Cell Biol. 9, M53-56.
DOI
ScienceOn
|
30 |
Shin, S. Y., Kim, C. G. and Lee, Y. H. (2013) Egr-1 regulates the transcription of the BRCA1 gene by etoposide. BMB Rep. 46, 92-96.
DOI
ScienceOn
|
31 |
Iida, M., Towatari, M., Nakao, A., Iida, H., Kiyoi, H., Nakano, Y., Tanimoto, M., Saito, H. and Naoe, T. (1999) Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation. Leukemia 13, 585-589.
DOI
|
32 |
Kawakami, Y., Rodriguez-Leon, J., Koth, C. M., Buscher, D., Itoh, T., Raya, A., Ng, J. K., Esteban, C. R., Takahashi, S., Henrique, D., Schwarz, M. F., Asahara, H. and Izpisua Belmonte, J. C. (2003) MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat. Cell Biol. 5, 513-519.
DOI
ScienceOn
|